Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$878K Sell
3,488
-70
-2% -$15.1K 0.11% 96
2026
Q1
$774K Sell
3,558
-37
-1% -$8.21K 0.11% 86
2025
Q4
$821K Buy
3,595
+1,070
+42% +$244K 0.12% 92
2025
Q3
$585K Sell
2,525
-156
-6% -$31.8K 0.11% 101
2025
Q2
$498K Buy
2,681
+60
+2% +$11.2K 0.09% 109
2025
Q1
$549K Buy
+2,621
New +$510K 0.11% 103

Other funds holding ABBV

IFC Advisors's ABBV Position: Q2 2026 in Review

IFC Advisors reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $15.1K and leaving 3,488 shares worth $878K. The position accounts for 0.11% of the portfolio, ranked #96.

IFC Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • IFC Advisors held 3,488 shares of AbbVie worth $878K as of Q2 2026.
  • IFC Advisors sold 70 AbbVie shares in Q2 2026, an estimated $15.1K.
  • AbbVie made up 0.11% of IFC Advisors's portfolio in Q2 2026, its #96 holding.
  • IFC Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IFC Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.